Nathan Connell: Bleeding Risk Is Not Limited to Delivery
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on Linkedln about a recent article published in Haemophilia Journal, co-authored by him and his colleagues, adding:
“Just published in Haemophilia Journal in conjunction with the World Federation of Hemophilia 2026 Congress in Kuala Lumpur, Malaysia: ‘Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders.’
Women and girls with inherited bleeding disorders have too often been under-recognized, under-diagnosed, and under-served.
This review highlights that bleeding risk is not limited to delivery.
It spans the reproductive lifespan, from heavy menstrual bleeding and iron deficiency, to fertility treatment, prenatal diagnosis, pregnancy planning, neuraxial anesthesia decisions, mode of delivery, and both primary and secondary postpartum hemorrhage.
A central message of the paper is that care must be proactive, multidisciplinary, and individualized.
For many patients, better outcomes depend on earlier recognition of bleeding symptoms, coordinated care across hematology, obstetrics, gynecology, anesthesia, and genetics, and thoughtful delivery planning well before labor.
The review also underscores how advances in preconception counseling, prenatal testing, and carrier evaluation are reshaping reproductive choice and risk assessment.
This is also a call to move beyond the historical framing of women only as ‘carriers’ and toward a model that recognizes their own bleeding phenotype, health risks, and need for lifelong care.
Grateful to my coauthors Joanna Davies, Rezan Abdul-Kadir, and Zane Kaplan for their partnership on this work.”
Title: Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders
Authors: Nathan T. Connell, Joanna Davies, Rezan Abdul-Kadir, Zane Kaplan
Other posts featuring Nathan Connell on Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics